Understanding Firearms Regulatory Guidance in the Cannabis Context
#70
Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
While this firearms regulatory guidance may seem distant from clinical cannabis practice, healthcare providers in states with legal cannabis should be aware that the intersection of federal firearms law and state cannabis legality creates significant safety documentation challenges. Patients who use cannabis and possess firearms occupy a legal gray zone where federal law prohibits firearm possession by unlawful drug users, yet state cannabis laws permit use, creating potential liability concerns for both patients and clinicians. The definition of “engaged in the business” as a dealer has indirect relevance to clinical settings where providers must navigate mandatory reporting requirements, state-to-federal law conflicts, and patient safety assessments involving both substances. Clinicians should recognize that counseling cannabis users about firearm safety and storage requires nuanced understanding of these overlapping legal frameworks and awareness of how cannabis documentation in medical records might intersect with federal firearms prohibitions. When assessing patients with concurrent cannabis use and firearm access, practitioners should document substance use patterns obj
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.

